Neos Therapeutics, Inc. NEOS
$ 1.15
-2.54%
Neos Therapeutics, Inc. Financial Ratios 2011-2024 | NEOS
Annual Financial Ratios Neos Therapeutics, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | -4.8 | -1.3 | -4.1 | -1.1 | -3.3 | - | - | - | - |
P/S |
- | 1.2 | 1.4 | 11.0 | 10.4 | 27.2 | - | - | - | - |
EV/EBITDA |
- | -17.5 | -1.8 | -5.6 | -1.8 | -2.0 | - | - | - | - |
PEG |
- | -0.06 | -0.03 | -0.09 | 0.06 | 0.02 | - | - | - | - |
P/B |
- | -13.1 | 8.6 | 34.8 | -61.7 | 1.3 | - | - | - | - |
P/CF |
- | -6.8 | -1.6 | -4.9 | -1.3 | -3.8 | - | - | - | - |
ROE % |
- | 275.73 | -658.70 | -839.63 | 5383.27 | -39.27 | - | - | - | - |
ROA % |
- | -18.60 | -46.40 | -61.71 | -103.98 | -25.13 | - | - | - | - |
ROCE % |
- | -37.85 | -80.17 | -81.74 | -130.62 | -24.94 | - | - | - | - |
DSO |
- | 150.0 | 203.0 | 199.5 | 244.6 | 375.7 | - | - | - | - |
DIO |
- | 160.0 | 140.5 | 396.5 | 184.0 | 165.8 | - | - | - | - |
DPO |
- | 96.6 | 172.6 | 337.6 | 248.9 | 317.4 | - | - | - | - |
All numbers in USD currency